tiprankstipranks
Trending News
More News >
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market

Xenetic Biosciences (XBIO) Stock Forecast & Price Target

Compare
339 Followers
See the Price Targets and Ratings of:

XBIO Financial Forecast

XBIO Earnings Forecast

The previous quarter’s earnings for XBIO were -$0.33.
The previous quarter’s earnings for XBIO were -$0.33.

XBIO Sales Forecast

The previous quarter’s earnings for XBIO were $1.03M.
The previous quarter’s earnings for XBIO were $1.03M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on XBIO
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
08/13/25
H.C. Wainwright Reaffirms Their Hold Rating on Xenetic Biosciences (XBIO)Valuation and risks to price target achievement. We maintain our Neutral rating. We look to potentially reassess our valuation of Xenetic pending visibility, in part, on timelines for entry of its lead DNase I asset into the clinic and initial path forward. Factors that could impact our valuation of the company include failed or inconclusive clinical trials, inability to raise sufficient funding to progress its programs, and commercialization risks. H.C. WAINWRIGHT & CO.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on XBIO
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
08/13/25
H.C. Wainwright Reaffirms Their Hold Rating on Xenetic Biosciences (XBIO)Valuation and risks to price target achievement. We maintain our Neutral rating. We look to potentially reassess our valuation of Xenetic pending visibility, in part, on timelines for entry of its lead DNase I asset into the clinic and initial path forward. Factors that could impact our valuation of the company include failed or inconclusive clinical trials, inability to raise sufficient funding to progress its programs, and commercialization risks. H.C. WAINWRIGHT & CO.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

XBIO Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
4
6
6
6
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
6
6
4
In the current month, XBIO has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. XBIO average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

XBIO Stock Forecast FAQ

What is XBIO’s average 12-month price target, according to analysts?
Currently, no data Available
What is XBIO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for XBIO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is XBIO a Buy, Sell or Hold?
      Xenetic Biosciences has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Xenetic Biosciences’s price target?
        Currently, no data Available
        What do analysts say about Xenetic Biosciences?
        Xenetic Biosciences’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of XBIO?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.